May 21, 2020 / 11:28 AM / 13 days ago

BRIEF-IMV Announces Selection Of A Vaccine Candidate Against Covid-19 To Advance Into Human Clinical Studies

May 21 (Reuters) - IMV Inc:

* IMV ANNOUNCES SELECTION OF A VACCINE CANDIDATE AGAINST COVID-19 TO ADVANCE INTO HUMAN CLINICAL STUDIES

* IMV INC - PHASE 1 CLINICAL STUDY OF DPX-COVID-19 IS SCHEDULED DURING SUMMER 2020

* IMV INC - MAJORITY OF 23 PEPTIDE EPITOPES SELECTED BY IMV DEMONSTRATED ROBUST ANTIBODY RESPONSES IN AN ANIMAL MODEL

* IMV INC - SELECTED MULTIPLE PEPTIDE EPITOPES TO BE FORMULATED WITHIN DPX PLATFORM TO FORM VACCINE CANDIDATE AGAINST NOVEL CORONAVIRUS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below